personal use reproduce permission Lancet Publishing GroupSEMINAR love doctorsthey dear must spend year year Investigating lot illness one got everybody young old frantic common cold eat hat know anything 1 common cold conventional term mild upper respiratory illness hallmark symptom whichare nasal stuffiness discharge sneezing sore throatand cough Although term tends imply isa single cause illness common cold actually heterogeneous group disease caused numerous virus belong several different family Thecommon cold usually selflimited illness confined tothe upper respiratory tract However patient theviral infection spread adjacent organ resulting indifferent clinical manifestation occasionally coldspredispose bacterial complication Despite usually benign nature illness common cold enormous economic burden society term visit doctor healthcareproviders treatment absence work school orday care Every year USA 25 million peoplevisit family doctor uncomplicated upperrespiratory infection 2and common cold syndrome result 20 million day absence work and22 million day absence school 3 Cause knowledge cause common cold islargely derived extensive family communityfollowup study undertaken 1960s Lancet 2003 361 5159 Department Paediatrics Turku University Hospital Turku Finland Heikkinen MD Department Medicine Division Infectious Diseases Helsinki University Central Hospital Helsinki Järvinen MD Correspondence Dr Terho Heikkinen Department Paediatrics Turku University Hospital FIN20520 Turku Finlandemail terhoheikkinenutufi1980s46Intensive research cause respiratory illness 1950s 1960s led discoveryof adenovirus parainfluenza virus rhinovirus respiratorysyncytial virus RSV enterovirus coronavirus inaddition influenza virus identified earlier figure 1 However era technique viral detection limited virusisolation viral cause could proven about25 patient respiratory infection 7 Improvements viral detection technique thepast two decade including various viral antigen detectionmethods particularly advent PCRbased assayshave substantially increased rate viral detection inclinical specimen 89 relative proportion different virus cause common cold vary dependent several factorssuch age season viral sampling detectionmethods However rhinovirus consistentlyfound common cause age group irrespective viral detection technique used panel 812Yearly rhinovirus account 3050 respiratory illnesses69but autumn peak season virus cause 80 upperrespiratory infection 8More 100 different serotypes rhinovirus identified relativeprevalences seem vary differentgeographical area also course time 10 Although scarce data available role coronaviruses cause common cold Theseviruses found 718 adult upperrespiratory infection 91314Parainfluenza virus RSVThe common cold Terho Heikkinen Asko JärvinenSeminar LANCET Vol 361 January 4 2003 wwwthelancetcom 51Despite great advance medicine common cold continues great burden society term human suffering economic loss several virus cause disease role rhinovirus mostprominent quarter cold still without proven cause recent discovery humanmetapneumovirus suggests virus could remain undiscovered Research inflammatorymechanisms common cold elucidated complexity virushost relation Increasing evidence also available central role virus predisposing complication New antiviral treatment cold developed optimum use agent would require rapid detection specific virus causing theinfection Although vaccine many respiratory virus could also become available ultimate prevention common cold seems remain distant aim Search strategy data seminar identified computeraided search PubMed Cochrane Library database usingkeywords relevant different section also reviewedthe journal reference list standard textbook usedour existing knowledge primary publication areaand new data presented international scientific meetingsWe selected report understanding havecontributed substantially current knowledge variousaspects common cold also potential forfurther readingFor personal use reproduce permission Lancet Publishing Groupadenoviruses enterovirus account minor proportion common cold syndrome therange illness caused virus alsoincludes manifestation typical tothese virus 1012Influenza often regarded disease entity separate common cold However theclinical presentation influenza range anasymptomatic infection severe illness thereforeoverlaps common cold Mild instance streptococcal pharyngitis clinically indistinguishable viral pharyngitis misclassified cold Despite availability sophisticated diagnostic method 2030 cold remain without aproven viral cause 69probably due part suboptimum method used collectiontransportation assay clinical specimen resultingin underdetection virus known exist Howevermany cold could also caused infectious agent yet identified explanation gained much support recent discovery new virus youngchildren respiratory infections15The relative effect virus tentatively named human metapneumovirus bycomparison respiratory virus stillundetermined Findings serological study 15indicate virus circulating human being atleast 50 year age 5 year virtually allchildren Netherlands infected Reports 1617 country suggest human metapneumovirus worldwide distribution Two virus found simultaneously 5 patient cold 18However rate dual viral infection increase proportionally number ofdifferent diagnostic method used 18and whether case really represent simultaneous infection bytwo virus unclear Positive finding PCR forinstance require presence live virus andviral genomic material detected patient long subsidence clinical symptom 1920 Epidemiology occurrence common cold show clear seasonality temperate region northernhemisphere frequency respiratory infectionsincreases rapidly autumn remains fairly highthroughout winter decrease spring tropical area cold arise rainy season incidence upper respiratory infection inverselyproportional age figure 2 average youngestchildren 68 adult 24 cold per year 57During first year life boy seem respiratoryinfections girl difference reversed later inlife 5Women work outside home fewer infection might beexplained greater exposure child whostay home 6Daycare attendance another major riskSEMINAR 52 LANCET Vol 361 January 4 2003 wwwthelancetcomViral cause common cold6912 Virus Estimated annual proportion case Rhinoviruses 3050 Coronaviruses 1015Influenza virus 515Respiratory syncytial virus 5Parainfluenza virus 5Adenoviruses 5Enteroviruses 5Metapneumovirus UnknownUnknown 2030Figure 1 Timeline discovery common respiratory virus Transmission electron micrograph three adenovirus particle shown background Science Photo LibraryRights granted include image electronic medium Please refer printed journalFor personal use reproduce permission Lancet Publishing Groupfactor respiratory illness child frequency cold increase number childrenin group 2123However frequent infection preschool year could lower frequency commoncold school year 23Some genetic factor might also affect individual susceptibility respiratoryinfections potential mechanism remain largelyunidentified 2425Psychological stress associated susceptibility common cold dosedependentmanner 26Finally reports27indicate heavy physical training increase risk respiratoryinfections whereas moderate physical activity coulddecrease risk central role rhinovirus cause common cold epidemiology condition largely parallel rhinovirus Although rhinovirusescan detected throughout year incidence ofrhinovirus infection peak autumn asubsequent smaller outbreak spring 2829Results followup study30showed high incidence rhinovirus infection child first year life age 6months 20 child laboratoryconfirmed rhinovirus infection age 2 year rhinovirusinfection documented virus culture PCR 79 child 91 antibody rhinovirus average annual rate rhinovirusinfection estimated 08 per person 28However figure likely underestimate calculationsbased PCR data might yield substantially higher rate Many virus cause common cold tend pattern seasonality temperate country RSV usually cause outbreak around turn year 31but pattern also documented32Influenza epidemic also typically occur winter northern hemisphere often overlappingwith RSV 3133 transmission virus cause upper respiratory infection occur three majormechanisms 1 hand contact secretion containthe virus either directly infected person orindirectly environmental surface 2 smallparticle aerosol lingering air extended time 3 direct hit largeparticle aerosol infectedperson Although mechanism likely beinvolved spread respiratory virus primaryroutes transmission differ virus Forinstance influenza virus thought spread mainlyvia smallparticle aerosol 34whereas hand contact followed selfinoculation virus nose oreye reported efficient way oftransmission rhinovirus 35However aerosol transmission rhinovirus also clearlydocumented 36Pathogenesis pathogenesis common cold involves complexinterplay replicating virus hostsinflammatory response detailed pathogeneticmechanisms various respiratory virus verydifferent indicated fact theprimary site replication influenza virus thetracheobronchial epithelium 34whereas rhinovirus repli cation start predominantly nasopharynx37The available evidence38albeit scarce lend support popular belief cold associated chilling orexposure cold environment Much understanding pathogenetic event common cold derived study volunteer infected rhinovirus 3537Rhinovirus infection begin deposition virus anterior nasal mucosaor eye get nose via thelacrimal duct virus transported theposterior nasopharynx mucociliary action adenoid area virus gain entrance epithelial cell binding specific receptor cell 90 ofrhinovirus serotypes use intercellular adhesion molecule1ICAM1 receptor 3940Once inside epithelial cell virus start replicate rapidly Progeny virusescan detected within 810 h intranasal inoculationof rhinovirus 41The infectious dose rhinovirus small42and 95 individual without antibody specific viral serotype infected afterintranasal challenge 43However reason still unknown infection lead clinical illness symptomaticcolds develop 75 infected person 43The shedding rhinovirus peak second day afterintranasal inoculation decrease rapidly thereafter butsmall amount virus discovered nasalsecretions 3 week infection 3744 Viral infection nasal mucosa result vasodilation increased vascular permeability inturn cause nasal obstruction rhinorrhoea arethe main clinical symptom common coldCholinergic stimulation lead increased mucous gland secretion sneezing detailed mechanism viral infection cause change nasalmucosa still incompletely understood Distinctdifferences exist degree epithelial destructionbetween various respiratory virus Whereas influenzaviruses adenovirus cause extensive damage therespiratory epithelium 4546no histopathological change observed nasal biopsy specimen individualsinfected rhinovirus 37The absence epithelial destruction rhinovirus infection led ideathat clinical symptom common cold might notbe caused direct cytopathic effect virus butinstead primarily caused inflammatory response host Extensive research role inflammatory mediator pathogenesis thecommon cold produced evidence increasedconcentrations several mediator kininsleukotrienes histamine interleukin 1 6 8 tumournecrosis factor RANTES regulated activationnormal cell expressed secreted nasalsecretions patient cold 4752The concentration interleukin 6 interleukin 8 nasal secretion correlatewith severity symptom 5354The host response mechanism triggered viral infection howeverinterrelated extremely complex far resolvedFor example respiratory epithelial cell infected withRSV interleukin 1 H9252and tumour necrosis factor H9251induce synthesis interleukin 8 24 h partly inhibit thesynthesis cytokine 48 h 55SEMINAR LANCET Vol 361 January 4 2003 wwwthelancetcom 531H110916001234567 1234591014151920242529303940495059Mean annual number illness per person Age year Figure 2 Mean annual incidence respiratory illness per person age group5For personal use reproduce permission Lancet Publishing GroupResults study shown effect common cold upper respiratory tract limitedto nasal cavity paranasal sinus alsofrequently affected CT scan plain radiograph ofsinuses obtained early course illness adult cold show substantial abnormality usually resolve spontaneously without antibiotic treatment 5657 finding imply sinus abnormalitiesobserved common cold evidence abacterial complication instead part normalcourse illness Findings experimental study 58 showed blowing nose creates highintranasal pressure could propel fluid nasalcavity paranasal sinus Furthermore rhinovirusRNA detected sinus aspirate even theabsence bacteria 59and result study60that used situ hybridisation provide evidence presence ofrhinovirus epithelial cell maxillary sinus inpatient acute sinusitis adult child viral infection upper respiratory tract often cause dysfunction Eustachian tube considered important factor thepathogenesis acute otitis medium 61Great middle ear negative pressure recorded preschool andschoolaged child cold 6263In adult volunteer challenged rhinovirus influenza virus normalEustachian tube function deteriorated 5080 ofindividuals 6465 Several respiratory viruseseg influenza virus RSV parainfluenza virusescan also infect lowerrespiratory tract ability rhinovirus replicatein lower airway much debated Althoughrhinoviruses detected secretion obtained lower airway bronchoscopy 66potential viral contamination upper respiratory tract notruled recently investigator one study 67 adult volunteer infected rhinovirus avoidedpotential contamination upper airway use ofinsitu hybridisation bronchial biopsy finding ofthe study showed conclusively rhinovirus able toreplicate lower airway Clinical manifestation symptom common cold arise anincubation period vary considerably betweendifferent virus experimental rhinovirus infection theonset symptom reported occur soon as1012 h intranasal inoculation virus 41whereas incubation period influenza range 1 7 day 34Generally severity symptom increase rapidly peak within 23 day infectionand decrease soon mean duration thecommon cold 710 day proportion patientssome symptom still present 3 week 86869 Rhinovirus infection typically start sore throat soon accompanied nasal stuffiness anddischarge sneezing cough soreness throatusually disappears quickly whereas initial wateryrhinorrhoea turn thicker purulent 70The purulence nasal discharge associated withchanges nasopharyngeal bacterial flora 71and considered indicate simultaneous bacterial infection ofthe nasal mucosa Fever infrequent finding duringrhinovirus infection adult fairly common inchildren upper respiratory infection cause 7273 symptom associated cold syndromeinclude hoarseness headache malaise lethargyMyalgia occasional complaint patient coldsalthough typical feature influenza infection 34Although common cold usually selflimited illness short duration viral infection sometimesaccompanied bacterial complication child themost common bacterial complication acute otitis mediawhich occurs 20 child viral upper respiratory infection 7475The seasonal incidence rate otitis medium closely parallel general occurrence viralrespiratory infection 7677and complication diagnosed frequently day 3 4 onset ofupper respiratory symptom 7879Findings study indicate respiratory virus play crucial part thedevelopment acute otitis medium 61and detection rate different virus middleear fluid suggest atleast virus actively invade middle ear andcontribute inflammatory process middle earmucosa 8083 common bacterial complication viral upper respiratory infection include sinusitis pneumoniaSinusitis estimated occur complication in052 cold 12but basis recent evidence high incidence sinus abnormality duringapparently uncomplicated cold difficult ascertainwhether change paranasal sinus represent realbacterial complication whether part natural history common cold 5657Pneumonia associated viral upper respiratory infection often atrue bacterial complication predisposing viral illnessbut also pure extension viral illness thepulmonary level Research microbial cause pneumonia suggested mixed viralbacterial infection common especially child 8485 Findings several study indicate clear association viral respiratory infection acuteexacerbations asthma adult child astudy 86of adult patient asthma symptom common cold reported 80 episode ofwheezing dyspnoea rhinovirus accounted forabout 60 asthma exacerbation theviral cause could identified central role rhinovirus triggering acute exacerbation asthma also well documented child 87In elderly population overall morbidity due respiratory virusesother influenza often underrated although resultsof surveillance study 13indicate two third elderly patient cold expected develop lowerrespiratory illness Individuals chronic obstructivepulmonary disease COPD form another important riskgroup viral infection 88Although frequency cold similar patient without COPD theuse medical resource including hospital admissionsand visit emergency clinic viral respiratoryillnesses substantially increased patient COPD 89 immunocompromised patient RSV usually mostcommon cause severe viral respiratory illness butrhinovirus infection also associated severeand even fatal lower respiratory tract disease 90 Diagnosis instance clinical diagnosis commoncold simple made reliably adult patientsthemselves 8However diagnosis sometimes problematic infant young child capable ofexpressing symptom Diagnosis infant isespecially difficult case fever leadingsymptom early phase infection doctor challenged distinguish benign viral infection severe invasive bacterial infection Allergic orvasomotor rhinitis sometimes mimic commoncold usually condition differentiatedSEMINAR 54 LANCET Vol 361 January 4 2003 wwwthelancetcomFor personal use reproduce permission Lancet Publishing Groupeasily soreness throat caused streptococcal pharyngitis often resembles initial symptom thecommon cold However nasal stuffiness dischargewhich primary symptom common cold areuntypical streptococcal pharyngitis Although case exudative tonsillitis child caused virus clinical finding inspection pharynxcannot reliably distinguish bacterial viral tonsillitis 91 child intranasal foreign body searchedfor case persistent nasal discharge particularly thedischarge unilateral Although respiratory infection caused different virus tend variation typical clinicalpresentations wide range clinical manifestationsof virus make virtually impossible ascertain thespecific virus causing problem individual patientwith common cold clinical ground alone 143492Even influenza often regarded distinct diseaseentity among respiratory viral infection positivepredictive value clinical sign symptom rangedbetween 27 79 9394 Methods identification virus include viral culture antigen detection PCR Isolation virus incell culture considered gold standard detectionbut little value clinical practice theslowness process Immunoperoxidase staining culture monoclonal antibody speed viral identification substantially result usually availablewithin 48 h 95Various antigen detection test frequently used identify influenza virus parainfluenza virusesRSV adenovirus 9697but technique routinely used detect rhinovirus hugenumber different serotypes exist Recentlydeveloped rapid antigen detection kit influenza andRSV provide result within 1530 min 9899but concern reallife sensitivity specificity ofthese test 100PCR proved valuable diagnosis viral infection general especially rhinovirus infectionsfor method suboptimum 89101102 However PCRbased technique still laborious foruse everyday clinical practice extremesensitivity PCR pose problem interpretationof result 1920 Nasopharyngeal aspirate nasal wash specimen usually considered specimen choice thedetection respiratory virus nasal throat swabsare also often used greater feasibility 103106 Scarce data available optimum samplingmethods best site collect specimen forviral detection could differ virus Treatment Since common cold caused multitude ofdifferent virus type varying pathogeneticmechanisms effective universal treatment thisdisorder developed understandable Thesymptomatic treatment cold aimed relieving disturbing symptom illness hundred different overthecounter preparation areavailable 107108Although antibiotic effective virus widely used treatment ofuncomplicated viral upper respiratory infection 2109 patient find nasal stuffiness discharge bothersome symptom common cold8Nasal blockage effectively reduced intranasally ororally administered decongestant 110Firstgeneration secondgeneration antihistamine reduce sneezingand rhinorrhoea probably anticholinergicrather antihistamine effect 111Results severalstudies also shown efficacy local ipratropium inreducing rhinorrhoea 112Theoretically corticosteroid potent antiinflammatory agent could thought toeffectively reduce nasal symptom result clinicalstudies either intranasal oral steroid shown noclinical benefit 4469113The use intranasal steroid child rhinovirus infection could even increasethe risk acute otitis medium 114Cough medication antitussive mucolytic agent frequently used although efficacy poorly shown115Non steroidal antiinflammatory drug reduce fever andsoreness throat might also beneficialeffect cough 116Data efficacy zinc reducing severity duration cold still inconclusive117 present specific antiviral treatment respiratory virus commercially available influenzaviruses usability amantadine rimantadine islimited sideeffects inefficacy againstinfluenza B virus rapid development resistant viral strain treatment 118The new influenzaspecific antiviral zanamivir oseltamivir fewer sideeffects effective influenza Bviruses treatment initiated within 48 h theonset symptom duration clinical illness reduced 12 day either drug 119120Scarce evidence exists efficacy drug theprevention bacterial complication especially highrisk patient 121but early treatment influenza oseltamivir reduce development acute otitismedia child 40 122 leading role rhinovirus common cold effective antiviral rhinovirusescould expected greatest effect thetreatment disease 1980s much hope laidon use interferon disappointingly provided nobenefit treatment naturally occurring cold orexperimental rhinovirus infection 123124The discovery ofSEMINAR LANCET Vol 361 January 4 2003 wwwthelancetcom 55 personal use reproduce permission Lancet Publishing GroupICAM1 main cellular receptor rhinovirus led attempt block attachment virus thereceptor using recombinant soluble decoy ICAM1Findings clinical trial showed approach couldreduce severity experimental rhinovirus infection effect modest 125 Recent advance antirhinoviral drug include development pleconaril novel viral capsid binder andruprintrivir human rhinovirus 3C protease inhibitor 126128 Pleconaril administered orally active awide range rhinovirus enterovirus Findings ofearly clinical trial indicated pleconariltreatment instituted within 2436 h onset symptom duration illness reduced 115 day 129 Increasing knowledge central role host inflammatory response producing symptom thecommon cold led attempt treat cold withcombinations antiviral antiinflammatory agent 130 recent trial131in adult challenged rhinovirus combination intranasal interferon oralchlorphenamine ibuprofen showed effect reducingnot nasal also several symptom theillness Prevention diversity viral cause common cold hashampered prevention well treatment initiative theabsence suitable common antigen across widerange rhinovirus serotypes prospect fordevelopment vaccine rhinovirus seem poor Influenza respiratory infection vaccine commercially available addition thepresent inactivated influenza vaccine isadministered intramuscularly new type influenzavaccines intranasal administration beendeveloped 132134Several type vaccine RSV parainfluenza virus also developed inearly clinical trial 135137 antiviral drug approach prevention respiratory infection currently influenza efficacy ofthe specific antiviral shown seasonalprophylaxis postexposure prophylaxis withinfamilies 138142Contrary lack effect treatment rhinovirus infection prophylactic efficacy ofintranasally administered interferon welldemonstrated unacceptably high rate nasaladverse event extended administration decreased enthusiasm use prevention cold 143In proof concept study144intranasally administered immunoglobulin reduced episode rhinitisin child investigation passiveimmunisation nasal mucosa published Despite widespread use vitamin C extract plant Echinacea prevention common cold conclusive evidence effect stilllacking 145146In view available data seems obvious complete prevention cold would possibleby total longterm isolation community 147While waiting next ship bound Antarctica howevermany people might find solace report 148that suggests intake wine especially red wine may aprotective effect common cold Future consideration Together substantial proportion cold withouta proven microbial cause recent discovery humanmetapneumovirus suggests importantrespiratory virus might still remain undetected theuse highly sophisticated molecular technique couldlead new discovery research hostinflammatory response viralbacterial interactionduring common cold might reveal pathway couldserve target intervention better alleviate symptom prevent development complication Optimum use newly available andforthcoming antiviral agent likely increase needfor simple rapid inexpensive accurate pointofcaretests identify specific virus causing infection onan individual level era everincreasingantimicrobial resistance bacteria effort aimed theeducation people ineffectiveness antibiotic treatment uncomplicated cold intensified Conflict interest statement Heikkinen received support research epidemiology respiratory viral infection Wyeth GlaxoSmithKline participated one local investigator Finland international multicentre study zanamivir sponsored GlaxoSmithKline hasreceived honorarium lecture area respiratory infection academic meeting organised various pharmaceutical company None source contributed content Seminar Järvinen conflict interest respect Seminar References 1 Herbert AP common cold Look back laugh London Methuen 1 960 11517 2 Gonzales R Malone DC Maselli JH Sande Excessive antibiotic use acute respiratory infection United States Clin Infect Dis 2001 3375762 3 Adams PF Hendershot GE Marano Current estimate National Health Interview Survey Vital Health Stat 1999 10 1996 4 Fox JP Hall CE Cooney MK Luce Kronmal RA Seattle virus watch 2 objective study population observation data processing summary illness J Epidemiol 1972 96 27085 5 Monto Ullman BM Acute respiratory illness American community Tecumseh study JAMA 1974 227 16469 6 Monto Sullivan KM Acute respiratory illness community frequency illness agent involved Epidemiol Infect 1993 110 14560 7 Monto Studies community family acute respiratory illness infection Epidemiol Rev 1994 1635173 8 Arruda E Pitkäranta Witek TJ Jr Doyle CA Hayden FG Frequency natural history rhinovirus infection adult autumn J Clin Microbiol 1997 35286468 9 Mäkelä MJ Puhakka Ruuskanen et al Viruses bacteria etiology common cold J Clin Microbiol 1998 3653942 10 Monto Bryan ER Ohmit Rhinovirus infection Tecumseh Michigan frequency illness number serotypes J Infect Dis 1987 156 4349 11 Vesa Kleemola Blomqvist et al Epidemiology documented viral respiratory infection acute otitis medium cohort child followed two twentyfour month age Pediatr Infect Dis J 2001 2057481 12 Gwaltney JM Jr common cold Mandell GL Bennett JE Dolin R ed Principles practice infectious disease 5th edn Philadelphia Churchill Livingstone 2 000 65165 13 Larson Reed SE Tyrrell DAJ Isolation rhinovirus coronaviruses 38 cold adult J Med Virol 1980 522129 14 Nicholson KG Kent J Hammersley V Cancio E Acute viral infection upper respiratory tract elderly people living community comparative prospective population based study disease burden BMJ 1997 315 106064 15 van den Hoogen BG de Jong JC Groen J et al newly discovered human pneumovirus isolated young child respiratorytract disease Nat Med 2001 771924 16 Nissen MD Siebert DJ Mackay IM Sloots TP Withers SJ Evidence human metapneumovirus Australian child Med J Aust 2002 176 188 17 Peret TCT Boivin G Li et al Characterization human metapneumoviruses isolated patient North America J Infect Dis 2002 185 166063 18 Drews AL Atmar RL Glezen WP et al Dual respiratory virus infection Clin Infect Dis 1997 25142129SEMINAR 56 LANCET Vol 361 January 4 2003 wwwthelancetcomFor personal use reproduce permission Lancet Publishing Group19 Johnston SL Sanderson G Pattemore PK et al Use polymerase chain reaction diagnosis picornavirus infection subject without respiratory symptom J Clin Microbiol 1993 31 11117 20 NoksoKoivisto J Kinnari TJ Lindahl P Hovi Pitkäranta Human picornavirus coronavirus RNA nasopharynx ofchildren without concurrent respiratory symptom J Med Virol 2002 6641720 21 Wald ER Dashefsky B Byers C Guerra N Taylor F Frequency severity infection day care J Pediatr 1988 112 54046 22 Alho OP Koivu Sorri Rantakallio P Risk factor recurrent acute otitis medium respiratory infection infancy Int J Pediatr Otorhinolaryngol 1990 1915161 23 Ball TM Holberg CJ Aldous MB Martinez FD Wright AL Influence attendance day care common cold birththrough 13 year age Arch Pediatr Adolesc Med 2002 156 12126 24 Casselbrant ML Mandel EM Fall PA et al heritability otitis medium twin triplet study JAMA 1999 282 212530 25 Pitkäranta NoksoKoivisto J Jäntti V et al Lowered yield virusinduced interferon production leukocyte culture risk recurrent respiratory infection child J Clin Virol 1999 14 199205 26 Cohen Tyrrell DAJ Smith AP Psychological stress susceptibility common cold N Engl J Med 1991 325 60612 27 Nieman DC Exercise upper respiratory tract infection immune system Med Sci Sports Exerc 1994 2612839 28 Gwaltney JM Jr Hendley JO Simon G Jordan WS Jr Rhinovirus infection industrial population 1 occurrence illness N Engl J Med 1966 275 126168 29 Monto Shope TC Schwartz SA Albrecht JK Intranasal interferonalpha 2b seasonal prophylaxis respiratory infection J Infect Dis 1986 154 12833 30 Blomqvist Roivainen Puhakka Kleemola Hovi Virological serological analysis rhinovirus infection thefirst two year life cohort child J Med Virol 2002 66 26368 31 Monto Cavallaro JJ Tecumseh study respiratory illness 2patterns occurrence infection respiratory pathogen 19651969 J Epidemiol 1971 9428089 32 Waris Pattern respiratory syncytial virus epidemic Finland twoyear cycle alternating prevalence group B J Infect Dis 1991 163 46469 33 Izurieta HS Thompson WW Kramarz P et al Influenza rate hospitalization respiratory disease among infant andyoung child N Engl J Med 2000 342 23239 34 Nicholson KG Human influenza Nicholson KG Webster RG Hay AJ ed Textbook influenza Oxford Blackwell Science1998 21964 35 Gwaltney JM Jr Moskalski PB Hendley JO Handtohand transmission rhinovirus cold Ann Intern Med 1978 8846367 36 Dick EC Jennings LC Mink KA Wartgow CD Inhorn SL Aerosol transmission rhinovirus cold J Infect Dis 1987 156 44248 37 Winther B Gwaltney JM Jr Mygind N Turner RB Hendley JO Sites rhinovirus recovery point inoculation upper airway JAMA 1986 256 176367 38 Douglas RG Jr Lindgren KM Couch RB Exposure cold environment rhinovirus common cold failure demonstrateeffect N Engl J Med 1968 279 74247 39 Staunton DE Merluzzi VJ Rothlein R et al cell adhesion molecule ICAM1 major surface receptor rhinovirus Cell1989 5684953 40 Winther B Arruda E Witek TJ et al Expression ICAM1 nasal epithelium level soluble ICAM1 nasal lavage fluid human experimental rhinovirus infection Arch Otolaryngol Head Neck Surg 2002 128 13136 41 Harris JM II Gwaltney JM Jr Incubation period experimental rhinovirus infection illness Clin Infect Dis 1996 23128790 42 Hendley JO Gwaltney JM Jr Mechanisms transmission rhinovirus infection Epidemiol Rev 1988 1024358 43 Gwaltney JM Jr Hayden FG Psychological stress common cold N Engl J Med 1992 326 64445 44 Gustafson LM Proud Hendley JO Hayden FG Gwaltney JM Jr Oral prednisone therapy experimental rhinovirus infection J Allergy Clin Immunol 1996 97100914 45 Treanor JJ Influenza virus Mandell GL Bennett JE Dolin R ed Principles practice infectious disease 5th ednPhiladelphia Churchill Livingstone 2 000 182349 46 Cherry JD Adenoviruses Feigin RD Cherry JD ed Textbook pediatric infectious disease 4th edn Philadelphia W B Saunders1998 166684 47 Naclerio RM Proud Lichtenstein LM et al Kinins generated experimental rhinovirus cold J Infect Dis 1988 157 1334248 Welliver RC Wong DT Sun et al development respiratory syncytial virusspecific IgE release histamine nasopharyngeal secretion infection N Engl J Med 1981 305 84146 49 Volovitz B Faden H Ogra PL Release leukotriene C4 respiratory tract acute viral infection J Pediatr 1988 112 21822 50 Noah TL Henderson FW Wortman IA et al Nasal cytokine production viral acute upper respiratory infection childhood J Infect Dis 1995 171 58492 51 Fritz RS Hayden FG Calfee DP et al Nasal cytokine chemokine response experimental influenza virus infection result placebocontrolled trial intravenous zanamivir treatment J Infect Dis 1999 180 58693 52 Saito Deskin RW Casola et al Respiratory syncytial virus induces selective production chemokine RANTES upper airway epithelial cell J Infect Dis 1997 175 497504 53 Zhu Z Tang W Ray et al Rhinovirus stimulation interleukin6 vivo vitro evidence nuclear factor H9260Bdependent transcriptional activation J Clin Invest 1996 9742130 54 Turner RB Weingand KW Yeh CH Leedy DW Association interleukin8 concentration nasal secretion severity symptom experimental rhinovirus cold Clin Infect Dis 1998 2684046 55 Patel JA Jiang Z Nakajima N Kunimoto Autocrine regulation interleukin8 interleukin1 H9251in respiratory syncytial virusinfected pulmonary epithelial cell vitro Immunology 1998 9550106 56 Gwaltney JM Jr Phillips CD Miller RD Riker DK Computed tomographic study common cold N Engl J Med 1994 330 2530 57 Puhakka Mäkelä MJ Alanen et al Sinusitis common cold J Allergy Clin Immunol 1998 102 40308 58 Gwaltney JM Jr Hendley JO Phillips CD et al Nose blowing propels nasal fluid paranasal sinus Clin Infect Dis 2000 30 38791 59 Pitkäranta Arruda E Malmberg H Hayden FG Detection rhinovirus sinus brushing patient acute community acquired sinusitis reverse transcriptionPCR J Clin Microbiol 1997 35179193 60 Pitkäranta Starck Savolainen et al Rhinovirus RNA maxillary sinus epithelium adult patient acute sinusitis Clin Infect Dis 2001 3390911 61 Heikkinen role respiratory virus otitis medium Vaccine 2000 19suppl 1 S5155 62 Sanyal Henderson FW Stempel EC Collier Denny FW Effect upper respiratory tract infection Eustachian tube ventilatory function preschool child J Pediatr 1980 971115 63 Winther B Hayden FG Arruda E et al Viral respiratory infection schoolchildren effect middle ear pressure Pediatrics 2002 109 82632 64 McBride TP Doyle WJ Hayden FG Gwaltney JM Jr Alterations eustachian tube middle ear nose rhinovirus infection Arch Otolaryngol Head Neck Surg 1989 115 105459 65 Doyle WJ Skoner DP Hayden F et al Nasal otologic effect experimental influenza virus infection Ann Otol Rhinol Laryngol 1994 103 5969 66 Halperin SA Eggleston PA Hendley JO et al Pathogenesis lower respiratory tract symptom experimental rhinovirus infection Rev Respir Dis 1983 128 80610 67 Papadopoulos NG Bates PJ Bardin PG et al Rhinoviruses infect lower airway J Infect Dis 2000 181 187584 68 Gwaltney JM Jr Hendley JO Simon G Jordan WS Jr Rhinovirus infection industrial population 2 characteristic illness antibody response JAMA 1967 202 494500 69 Puhakka Mäkelä MJ Malmström K et al common cold effect intranasal fluticasone propionate treatment J Allergy Clin Immunol 1998 101 72631 70 Igarashi Skoner DP Doyle WJ et al Analysis nasal secretion experimental rhinovirus upper respiratory infection J Allergy Clin Immunol 1993 9272231 71 Winther B Brofeldt Gronborg H et al Study bacteria nasal cavity nasopharynx naturally acquired common cold Acta Otolaryngol 1984 9831520 72 Putto Ruuskanen Meurman Fever respiratory virus infection J Dis Child 1986 140 115963 73 Dick EC Inhorn SL Glezen WP Rhinoviruses Feigin RD Cherry JD ed Textbook pediatric infectious disease 4th edn Philadelphia W B Saunders 1 998 183965 74 Heikkinen Ruuskanen Ziegler Waris Puhakka H Short term use amoxicillinclavulanate upper respiratory tractinfection prevention acute otitis medium J Pediatr 1995 126 31316SEMINAR LANCET Vol 361 January 4 2003 wwwthelancetcom 57For personal use reproduce permission Lancet Publishing Group75 Tapiainen Luotonen L Kontiokari Renko Uhari Xylitol administered respiratory infection failed prevent acute otitis medium Pediatrics 2002 109 e19 76 Henderson FW Collier Sanyal et al longitudinal study respiratory virus bacteria etiology acute otitis medium effusion N Engl J Med 1982 306 137783 77 Ruuskanen Arola PuttoLaurila et al Acute otitis medium respiratory virus infection Pediatr Infect Dis J 1989 8 9499 78 Heikkinen Ruuskanen Temporal development acute otitis medium upper respiratory tract infection Pediatr Infect Dis J 1994 1365961 79 Koivunen P Kontiokari Niemelä Pokka Uhari Time development acute otitis medium upper respiratory tract infection child Pediatr Infect Dis J 1999 1830305 80 Chonmaitree Owen MJ Howie VM Respiratory virus interfere bacteriologic response antibiotic child acute otitismedia J Infect Dis 1990 162 54649 81 Arola Ziegler Ruuskanen Respiratory virus infection cause prolonged symptom acute otitis medium J Pediatr 1990 116 697701 82 Pitkäranta Virolainen Jero J Arruda E Hayden FG Detection rhinovirus respiratory syncytial virus coronavirus infection inacute otitis medium reverse transcriptase polymerase chain reactionPediatrics 1998 102 29195 83 Heikkinen Thint Chonmaitree Prevalence various respiratory virus middle ear acute otitis medium N Engl J Med 1999 340 26064 84 Juvén Mertsola J Waris et al Etiology communityacquired pneumonia 254 hospitalized child Pediatr Infect Dis J 2000 19 29398 85 HeiskanenKosma Korppi Jokinen C et al Etiology childhood pneumonia serologic result prospective population based study Pediatr Infect Dis J 1998 1798691 86 Nicholson KG Kent J Ireland DC Respiratory virus exacerbation asthma adult BMJ 1993 307 98286 87 Johnston SL Pattemore PK Sanderson G et al Community study role viral infection exacerbation asthma 911 year old child BMJ 1995 310 122529 88 Seemungal HarperOwen R Bhowmik et al Respiratory virus symptom inflammatory marker acute exacerbation stable chronic obstructive pulmonary disease J Respir Crit Care Med 2001 164 161823 89 Greenberg SB Allen Wilson J Atmar RL Respiratory viral infection adult without chronic obstructive pulmonary disease J Respir Crit Care Med 2000 162 16773 90 Ghosh Champlin R Couch R et al Rhinovirus infection myelosuppressed adult blood marrow transplant recipient Clin Infect Dis 1999 2952832 91 Putto Febrile exudative tonsillitis viral streptococcal Pediatrics 1987 80612 92 Walsh EE Falsey AR Hennessey PA Respiratory syncytial virus infection person chronic cardiopulmonary diseaseAm J Respir Crit Care Med 1999 160 79195 93 Carrat F Tachet Rouzioux C Housset B Valleron AJ Evaluation clinical case definition influenza detailed investigation patientsduring 19951996 epidemic France Clin Infect Dis 1999 28 28390 94 Monto Gravenstein Elliott Colopy Schweinle J Clinical sign symptom predicting influenza infection Arch Intern Med 2000 160 324347 95 Waris Ziegler Kivivirta Ruuskanen Rapid detection respiratory syncytial virus influenza virus cell culture byimmunoperoxidase staining monoclonal antibody J Clin Microbiol 1990 28115962 96 Kim HW Wyatt RG Fernie BF et al Respiratory syncytial virus detection immunofluorescence nasal secretion monoclonal antibody selected surface internal protein J Clin Microbiol 1983 181399404 97 Nikkari Halonen P Kharitonenkov et al Oneincubation time resolved fluoroimmunoassay based monoclonal antibody detection influenza B virus directly clinical specimen J Virol Methods 1989 232940 98 Cox NJ Subbarao K Influenza Lancet 1999 354 127782 99 Krilov LR Lipson SM Barone SR et al Evaluation rapid diagnostic test respiratory syncytial virus RSV potential bedside diagnosis Pediatrics 1994 9390306 100 Monto Herlocher ML Rotthoff J Bidol SA Detection control influenza outbreak Michigan nursing home Program Abstracts 39th Annual Meeting Infectious DiseasesSociety America San Francisco USA 2001 abstr 888 101 Hyypiä Puhakka Ruuskanen et al Molecular diagnosis ofhuman rhinovirus infection comparison virus isolation J Clin Microbiol 1998 36208183 102 Fan J Henrickson KJ Savatski Rapid simultaneous diagnosis infection respiratory syncytial virus B influenza virus B human parainfluenza virus type 1 2 3 multiplex quantitative reverse transcriptionpolymerase chain reaction enzyme hybridization assay Hexaplex Clin Infect Dis 1998 26 1397402 103 McIntosh K Halonen P Ruuskanen Report workshop respiratory viral infection epidemiology diagnosis treatment prevention Clin Infect Dis 1993 1615164 104 Hall CB Douglas RG Jr Clinically useful method isolation respiratory syncytial virus J Infect Dis 1975 131 15 105 Covalciuc KA Webb KH Carlson CA Comparison four clinical specimen type detection influenza B virus optical immunoassay FLU OIA test cell culture method J Clin Microbiol 1999 37397174 106 Heikkinen Salmi AA Ruuskanen Comparative study nasopharyngeal aspirate nasal swab specimen detection ofinfluenza BMJ 2001 322 138 107 Smith MB Feldman W Overthecounter cold medication critical review clinical trial 1950 1991 JAMA 1993 269 225863 108 Lowenstein SR Parrino TA Management common cold Adv Intern Med 1987 3220733 109 Arroll B Kenealy Antibiotics common cold Cochrane Review Cochrane Library Issue 3 Oxford Update Software 2002 110 Sperber SJ Sorrentino JV Riker DK Hayden FG Evaluation alpha agonist alone combination nonsteroidal antiinflammatory agent treatment experimental rhinoviruscolds Bull N Acad Med 1989 6514560 111 Gwaltney JM Jr Druce HM Efficacy brompheniramine maleate treatment rhinovirus cold Clin Infect Dis 1997 25 118894 112 Hayden FG Diamond L Wood PB Korts DC Wecker MT Effectiveness safety intranasal ipratropium bromide common cold randomized doubleblind placebocontrolled trialAnn Intern Med 1996 125 8997 113 Farr BM Gwaltney JM Jr Hendley JO et al randomized controlled trial glucocorticoid prophylaxis experimental rhinovirus infection J Infect Dis 1990 162 117377 114 Ruohola Heikkinen Waris Puhakka Ruuskanen Intranasal fluticasone propionate prevent acute otitis medium viral upper respiratory infection child J Allergy Clin Immunol 2000 106 46771 115 Schroeder K Fahey Overthecounter medication acute cough child adult ambulatory setting Cochrane Review Cochrane Library Issue 2 Oxford Update Software 2002 116 Sperber SJ Hendley JO Hayden FG et al Effects naproxen experimental rhinovirus cold randomized doubleblindcontrolled trial Ann Intern Med 1992 117 3741 117 Marshall Zinc common cold Cochrane Review Cochrane Library Issue 2 Oxford Update Software 2002 118 Hayden FG Belshe RB Clover RD et al Emergence apparent transmission rimantadineresistant influenza virus family N Engl J Med 1989 321 1696702 119 MIST Study Group Randomised trial efficacy safety inhaled zanamivir treatment influenza B virus infectionsLancet 1998 352 187781 120 Nicholson KG Aoki FY Osterhaus AD et al Efficacy safety oseltamivir treatment acute influenza randomised controlled trial Lancet 2000 355 184550 121 Kaiser L Keene Hammond JMJ Elliott Hayden FG Impact zanamivir antibiotic use respiratory event following acute influenza adolescent adult Arch Intern Med 2000 160 323440 122 Whitley RJ Hayden FG Reisinger KS et al Oral oseltamivir treatment influenza child Pediatr Infect Dis J 2001 20 12733 123 Hayden FG Gwaltney JM Jr Intranasal interferonalpha 2 treatment experimental rhinoviral cold J Infect Dis 1984 150 17480 124 Hayden FG Kaiser DL Albrecht JK Intranasal recombinant alfa2b interferon treatment naturally occurring common coldsAntimicrob Agents Chemother 1988 3222430 125 Turner RB Wecker MT Pohl G et al Efficacy tremacamra soluble intercellular adhesion molecule 1 experimental rhinovirus infection randomized clinical trial JAMA 1999 281 1797804 126 Schiff GM Sherwood JR Clinical activity pleconaril anSEMINAR 58 LANCET Vol 361 January 4 2003 wwwthelancetcomFor personal use reproduce permission Lancet Publishing Groupexperimentally induced coxsackievirus A21 respiratory infection J Infect Dis 2000 181 2026 127 Kaiser L Crump CE Hayden FG vitro activity pleconaril AG7088 selected serotypes clinical isolates human rhinovirus Antiviral Res 2000 4721520 128 Hsyu PH Pithavala YK Gersten Penning CA Kerr BM Pharmacokinetics safety antirhinoviral agent ruprintrivir healthy volunteer Antimicrob Agents Chemother 2002 46 39297 129 Hayden FG Coats Kim K et al Oral pleconaril treatment picornavirusassociated viral respiratory illness adult efficacy tolerability phase II clinical trial Antivir Ther 2002 75365 130 Gwaltney JM Jr Combined antiviral antimediator treatment rhinovirus cold J Infect Dis 1992 166 77682 131 Gwaltney JM Jr Winther B Patrie JT Hendley JO Combined antiviralantimediator treatment common cold J Infect Dis 2002 186 14754 132 Belshe RB Mendelman PM Treanor J et al efficacy live attenuated coldadapted trivalent intranasal influenzavirus vaccine child N Engl J Med 1998 338 140512 133 Nichol KL Mendelman PM Mallon KP et al Effectiveness live attenuated intranasal influenza virus vaccine healthy working adult randomized controlled trial JAMA 1999 282 13744 134 Glueck R Preclinical clinical investigation safety novel adjuvant intranasal immunization Vaccine 2001 20suppl 1 S4244 135 Crowe JE Jr Respiratory syncytial virus vaccine development Vaccine 2001 20suppl 1 S3237 136 Lee MS Greenberg DP Yeh SH et al Antibody response bovine parainfluenza virus type 3 PIV3 vaccination human PIV3 infection young infant J Infect Dis 2001 184 90913 137 Skiadopoulos MH Tatem JM Surman SR et al recombinant chimeric human parainfluenza virus type 1 vaccine candidate rHPIV31cp45 attenuated immunogenic protective African green monkey Vaccine 2002 20184652138 Dolin R Reichman RC Madore HP et al controlled trial amantadine rimantadine prophylaxis influenza infection N Engl J Med 1982 307 58084 139 Monto Robinson DP Herlocher ML et al Zanamivir prevention influenza among healthy adult randomized controlled trial JAMA 1999 282 3135 140 Hayden FG Atmar RL Schilling et al Use selective oral neuraminidase inhibitor oseltamivir prevent influenza N Engl J Med 1999 341 133643 141 Hayden FG Gubareva LV Monto et al Inhaled zanamivir prevention influenza family N Engl J Med 2000 343 128289 142 Welliver R Monto Carewicz et al Effectiveness oseltamivir preventing influenza household contact randomizedcontrolled trial JAMA 2001 285 74854 143 Douglas RM Moore BW Miles HB et al Prophylactic efficacy intranasal alpha 2interferon rhinovirus infection family setting N Engl J Med 1986 314 6570 144 Heikkinen Ruohola Ruuskanen et al Intranasally administered immunoglobulin prevention rhinitis inchildren Pediatr Infect Dis J 1998 1736772 145 Douglas RM Chalker EB Treacy B Vitamin C preventing treating common cold Cochrane Review Cochrane Library Issue 2 Oxford Update Software 2002 146 Melchart Linde K Fischer P Kaesmayr J Echinacea preventing treating common cold Cochrane Review Cochrane Library Issue 2 Oxford Update Software 2002 147 Warshauer DM Dick EC Mandel AD Flynn TC Jerde RS Rhinovirus infection isolated Antarctic station transmission virus susceptibility population J Epidemiol 1989 129 31940 148 Takkouche B RegueiraMéndez C GarciaClosas R et al Intake wine beer spirit risk clinical common cold J Epidemiol 2002 155 85358SEMINAR LANCET Vol 361 January 4 2003 wwwthelancetcom 59Mistakes lesson past H BawaskarUses error Bawaskar Hospital Research Center Mahad Raigad Maharashtra India 402301 H Bawaskar MDA 16yearold boy bitten finger krait 0300 h sleeping floor hut reported tomy clinic 0500 h walked examination roombut bilateral ptosis bulbar palsy unable totalk gave antivenom intravenous atropine neostigamine soon removed intravenous needle vomited aspirated died patient paralysed anelapid snake bite treated semiprone positionand intubated 6yearold boy stung scorpion admitted rural hospital called examine child hadsigns suggestive autonomic storm advised oralprazosin staff nurse handed prazosin tablet mother administration child refused take tablet mother insist happythat nurse gave tetanus toxoid scorpionantivenin injection child developed pulmonaryoedema medical officer transferred cottagehospital without calling child died wayPrazosin antidote venom administered doctor nurse One confirm thatit started acting observing lowering blood pressureimprovement peripheral circulation reduction heart rate reappearance local pain site sting mild absent due vasoconstriction 62yearold retired man came alone Mumbai visit village developed chest pain bystandersbrought clinic electrocardiogram showedan extensive acute anterior myocardial infarction sedatedhim gave aspirin wanted give steptokinase bystander would pay notrelatives packed back Mumbai admitted cardiogenic shock died within 12 h admission since kept 15 million unit ofstreptokinase treatment room given topatients acute myocardial infarct without prepayment treated 74 patient like goodresults